New Boston Medical, Inc.
This investment has a biotech ROI with none of the biotech risks. We present 5 companies that have exited in the CMO space over the past...
We present 5 exits that have taken place over the past few years as evidence of our ability to sell this company. NBM is a contract manufacturer in the biotech arena. There are 2 compelling reasons to invest: the expected ROI and our probability of success. We don't bear the risk of a single technology to be successful and we're not reliant upon the drug that we put into the vials to be approved by the FDA.